US 2011/0257175 A1Published application

Selected Inhibitors of Protein Tyrosine Kinase Activity

AssigneeMethylGene Inc.

InventorsStëphane Raeppel, Lijie Zhan, Stephen William Claridge, Franck Raeppel, Frëdëric Gaudette, Arkadii Vaisburg

Life of this patent

Estimating the term…

Abstract

The invention provides new compounds and compositions thereof. The invention also provides methods for treating ophthalmic diseases, disorders and conditions.

Claims15

Dependent claims

A compound selected from the group consisting of

and hydrates, solvates, pharmaceutically acceptable salts, prodrugs and complexes thereof, and racemic and scalemic mixtures, diastereomers and enantiomers thereof.

Dependencies are inferred from the claim text.

Facts

Application: 13/082,944Filed 8 Apr 2011
Priority: 16 Apr 2010
Published: 20 Oct 2011
Term ends: Not estimatedThe source records don’t support an estimate.

Classification14 codes

C07D 495/04
In which the condensed system contains two hetero rings: ortho-condensed systems
A61K 38/005
Medicinal preparations containing peptides: enzyme inhibitors
A61P 9/10
Drugs for disorders of the cardiovascular system: for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary…
A61P 27/02
Drugs for disorders of the senses: ophthalmic agents

Family

Application61/324,803Us provisional application · filed 16 Apr 2010
US 8,455,484 B2Related patent
US 2011/0257175 A1This patent

From the US filing history. Foreign family members aren’t listed.

Timeline

Citations

Open elsewhere

patentgrep

Loading patent…